首页> 美国卫生研究院文献>3 Biotech >Analysis of toxic antidiabetic and antioxidant potential of Bambusa balcooa Roxb. leaf extracts in alloxan-induced diabetic rats
【2h】

Analysis of toxic antidiabetic and antioxidant potential of Bambusa balcooa Roxb. leaf extracts in alloxan-induced diabetic rats

机译:鲍氏鲍克斯鲍克斯的毒性抗糖尿病和抗氧化潜力的分析。四氧嘧啶致糖尿病大鼠的叶提取物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bambusa balcooa (Poaceae) is native to India and has been used traditionally by the tribes of Northeast India to treat diabetes. The present investigation was aimed to evaluate the toxicity, anti-diabetic activity along with in vitro antioxidant activity of the leaf of B. balcooa in alloxan-induced diabetic rats and also identify active compounds by using HPLC. The acute toxicity test of aqueous extract of B. balcooa leaf revealed that the median lethal dose (LD50) of B. balcooa aqueous extract (BAQE) was 5.18 g/kg body weight in mice. Administration of BAQE at 100 and 200 mg/kg in alloxan-induced diabetic rats showed significant reduction in fasting blood glucose and glycated hemoglobin while plasma insulin level was elevated compared to diabetic control. Both the doses were effective when compared to diabetic glibenclamide rats. The BAQE treated diabetic rats showed significant increase in the endogenous antioxidant enzymes superoxide dismutase, glutathione peroxidase and decrease in malondialdehyde levels. HPLC analysis of BAQE showed the presence of rutin, gallic acid and β sitosterol. Thus, it can be inferred from this study that BAQE possess antidiabetic and in vivo antioxidant activity. The overall activity might be possibly due to the presence of potential antioxidants.
机译:Bambusa balcooa(禾本科)原产于印度,印度东北部部落传统上一直使用它来治疗糖尿病。本研究旨在评估在四氧嘧啶诱导的糖尿病大鼠中B. balcooa叶片的毒性,抗糖尿病活性以及体外抗氧化活性,并通过HPLC鉴定活性化合物。 B. Balcooa叶水提物的急性毒性试验表明,B。Balcooa水提物(BAQE)在小鼠中的致死剂量(LD50)为5.18 g / kg体重。与四氧嘧啶相比,在四氧嘧啶诱导的糖尿病大鼠中以100和200 mg / kg的剂量施用BAQE显示,空腹血糖和糖化血红蛋白显着降低,而血浆胰岛素水平则比糖尿病对照组高。与糖尿病格列本脲大鼠相比,两种剂量均有效。 BAQE治疗的糖尿病大鼠内源性抗氧化酶超氧化物歧化酶,谷胱甘肽过氧化物酶显着增加,丙二醛水平降低。 BAQE的HPLC分析表明存在芦丁,没食子酸和β-谷甾醇。因此,从该研究可以推断出BAQE具有抗糖尿病和体内抗氧化活性。总体活性可能是由于潜在抗氧化剂的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号